Free Trial

Utah Medical Products (UTMD) Competitors

Utah Medical Products logo
$63.43 +0.21 (+0.33%)
Closing price 10/8/2025 04:00 PM Eastern
Extended Trading
$63.33 -0.10 (-0.16%)
As of 10/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAE

Should you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry.

Utah Medical Products vs. Its Competitors

Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

Cerus has a consensus price target of $3.50, suggesting a potential upside of 108.33%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than Utah Medical Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Utah Medical Products
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cerus
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Utah Medical Products$40.90M4.98$13.87M$3.7416.96
Cerus$192.51M1.67-$20.92M-$0.10-16.80

Utah Medical Products has a net margin of 32.34% compared to Cerus' net margin of -9.81%. Utah Medical Products' return on equity of 10.55% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
Utah Medical Products32.34% 10.55% 10.13%
Cerus -9.81%-33.77%-9.32%

Utah Medical Products has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500.

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 7.4% of Utah Medical Products shares are owned by insiders. Comparatively, 5.6% of Cerus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Utah Medical Products had 1 more articles in the media than Cerus. MarketBeat recorded 4 mentions for Utah Medical Products and 3 mentions for Cerus. Cerus' average media sentiment score of 1.53 beat Utah Medical Products' score of 0.73 indicating that Cerus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Utah Medical Products
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Utah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks.

Get Utah Medical Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTMD vs. The Competition

MetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$202.67M$10.66B$6.11B$10.56B
Dividend Yield1.93%1.87%5.69%4.75%
P/E Ratio16.9621.8785.4827.60
Price / Sales4.9832.53616.90236.99
Price / Cash12.8225.4637.9261.55
Price / Book1.833.4513.136.76
Net Income$13.87M$208.83M$3.30B$275.88M
7 Day Performance-0.69%1.63%4.29%2.81%
1 Month Performance1.00%2.06%9.45%9.24%
1 Year Performance-3.43%-5.12%86.64%35.42%

Utah Medical Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTMD
Utah Medical Products
2.5905 of 5 stars
$63.43
+0.3%
N/A-2.5%$202.67M$40.90M16.96180News Coverage
Analyst Forecast
CERS
Cerus
2.3658 of 5 stars
$1.54
+1.0%
$3.50
+128.0%
-2.3%$294.26M$192.51M-15.35290Positive News
Analyst Forecast
Short Interest ↑
OSUR
OraSure Technologies
1.9117 of 5 stars
$3.16
-0.8%
$3.00
-4.9%
-20.8%$230.76M$185.83M-4.71840News Coverage
Positive News
Analyst Forecast
ANIK
Anika Therapeutics
4.2385 of 5 stars
$9.17
+0.3%
$18.00
+96.4%
-62.5%$132.55M$114.55M-2.22300News Coverage
Analyst Forecast
WST
West Pharmaceutical Services
4.864 of 5 stars
$261.19
+0.3%
$318.56
+22.0%
-6.5%$18.78B$2.89B39.1010,600Analyst Forecast
COO
Cooper Companies
4.0187 of 5 stars
$67.90
+0.3%
$86.64
+27.6%
-33.5%$13.51B$3.90B33.4716,000Analyst Forecast
ALGN
Align Technology
4.8509 of 5 stars
$123.73
-2.1%
$215.00
+73.8%
-43.1%$8.99B$4.00B20.9220,945Analyst Forecast
MMSI
Merit Medical Systems
4.6929 of 5 stars
$81.18
+0.4%
$107.50
+32.4%
-12.5%$4.81B$1.36B41.227,400Analyst Forecast
ICUI
ICU Medical
4.4577 of 5 stars
$117.04
0.0%
$181.00
+54.6%
-32.5%$2.89B$2.37B-77.0415,000Analyst Forecast
XRAY
DENTSPLY SIRONA
4.8844 of 5 stars
$12.63
+0.2%
$18.64
+47.5%
-49.4%$2.52B$3.67B-2.6714,000Analyst Forecast
HAE
Haemonetics
4.9358 of 5 stars
$47.71
-0.8%
$78.78
+65.1%
-33.5%$2.30B$1.35B14.593,023Trending News
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:UTMD) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners